247 related articles for article (PubMed ID: 28695110)
1. Ror2 Signaling and Its Relevance in Breast Cancer Progression.
Bayerlová M; Menck K; Klemm F; Wolff A; Pukrop T; Binder C; Beißbarth T; Bleckmann A
Front Oncol; 2017; 7():135. PubMed ID: 28695110
[TBL] [Abstract][Full Text] [Related]
2. WNT11/ROR2 signaling is associated with tumor invasion and poor survival in breast cancer.
Menck K; Heinrichs S; Wlochowitz D; Sitte M; Noeding H; Janshoff A; Treiber H; Ruhwedel T; Schatlo B; von der Brelie C; Wiemann S; Pukrop T; Beißbarth T; Binder C; Bleckmann A
J Exp Clin Cancer Res; 2021 Dec; 40(1):395. PubMed ID: 34911552
[TBL] [Abstract][Full Text] [Related]
3. The Wnt5a/Ror2 noncanonical signaling pathway inhibits canonical Wnt signaling in K562 cells.
Yuan Y; Niu CC; Deng G; Li ZQ; Pan J; Zhao C; Yang ZL; Si WK
Int J Mol Med; 2011 Jan; 27(1):63-9. PubMed ID: 21069266
[TBL] [Abstract][Full Text] [Related]
4. Expression of the novel Wnt receptor ROR2 is increased in breast cancer and may regulate both β-catenin dependent and independent Wnt signalling.
Henry C; Quadir A; Hawkins NJ; Jary E; Llamosas E; Kumar D; Daniels B; Ward RL; Ford CE
J Cancer Res Clin Oncol; 2015 Feb; 141(2):243-54. PubMed ID: 25209439
[TBL] [Abstract][Full Text] [Related]
5. Characterization and impact of non-canonical WNT signaling on outcomes of urothelial carcinoma.
Meagher M; Krause H; Elliott A; Farrell A; Antonarakis ES; Bastos B; Heath EI; Jamieson C; Stewart TF; Bagrodia A; Nabhan C; Oberley M; McKay RR; Salmasi A
Cancer Med; 2024 Apr; 13(7):e7148. PubMed ID: 38558536
[TBL] [Abstract][Full Text] [Related]
6. Prognostic significance of Ror2 and Wnt5a expression in medulloblastoma.
Lee SE; Lim SD; Kang SY; Suh SB; Suh YL
Brain Pathol; 2013 Jul; 23(4):445-53. PubMed ID: 23278988
[TBL] [Abstract][Full Text] [Related]
7. Ror2-mediated alternative Wnt signaling regulates cell fate and adhesion during mammary tumor progression.
Roarty K; Pfefferle AD; Creighton CJ; Perou CM; Rosen JM
Oncogene; 2017 Oct; 36(43):5958-5968. PubMed ID: 28650466
[TBL] [Abstract][Full Text] [Related]
8. Myeloma cells inhibit non-canonical wnt co-receptor ror2 expression in human bone marrow osteoprogenitor cells: effect of wnt5a/ror2 pathway activation on the osteogenic differentiation impairment induced by myeloma cells.
Bolzoni M; Donofrio G; Storti P; Guasco D; Toscani D; Lazzaretti M; Bonomini S; Agnelli L; Capocefalo A; Dalla Palma B; Neri A; Nicolini F; Lisignoli G; Russo F; Colla S; Aversa F; Giuliani N
Leukemia; 2013 Feb; 27(2):451-63. PubMed ID: 22781592
[TBL] [Abstract][Full Text] [Related]
9. Targeting the ROR1 and ROR2 receptors in epithelial ovarian cancer inhibits cell migration and invasion.
Henry C; Llamosas E; Knipprath-Meszaros A; Schoetzau A; Obermann E; Fuenfschilling M; Caduff R; Fink D; Hacker N; Ward R; Heinzelmann-Schwarz V; Ford C
Oncotarget; 2015 Nov; 6(37):40310-26. PubMed ID: 26515598
[TBL] [Abstract][Full Text] [Related]
10. Wnt5a-Ror2 signaling between osteoblast-lineage cells and osteoclast precursors enhances osteoclastogenesis.
Maeda K; Kobayashi Y; Udagawa N; Uehara S; Ishihara A; Mizoguchi T; Kikuchi Y; Takada I; Kato S; Kani S; Nishita M; Marumo K; Martin TJ; Minami Y; Takahashi N
Nat Med; 2012 Feb; 18(3):405-12. PubMed ID: 22344299
[TBL] [Abstract][Full Text] [Related]
11. Wnt5a induces ROR1 and ROR2 to activate RhoA in esophageal squamous cell carcinoma cells.
Wu X; Yan T; Hao L; Zhu Y
Cancer Manag Res; 2019; 11():2803-2815. PubMed ID: 31114334
[No Abstract] [Full Text] [Related]
12. ROR2 promotes the epithelial-mesenchymal transition by regulating MAPK/p38 signaling pathway in breast cancer.
Xu J; Shi J; Tang W; Jiang P; Guo M; Zhang B; Ma G
J Cell Biochem; 2020 Oct; 121(10):4142-4153. PubMed ID: 32048761
[TBL] [Abstract][Full Text] [Related]
13. The Ror-Family Receptors in Development, Tissue Regeneration and Age-Related Disease.
Endo M; Kamizaki K; Minami Y
Front Cell Dev Biol; 2022; 10():891763. PubMed ID: 35493090
[TBL] [Abstract][Full Text] [Related]
14. A Novel Role for the BMP Antagonist Noggin in Sensitizing Cells to Non-canonical Wnt-5a/Ror2/Disheveled Pathway Activation.
Bernatik O; Radaszkiewicz T; Behal M; Dave Z; Witte F; Mahl A; Cernohorsky NH; Krejci P; Stricker S; Bryja V
Front Cell Dev Biol; 2017; 5():47. PubMed ID: 28523267
[TBL] [Abstract][Full Text] [Related]
15. Human Cytomegalovirus Modulates Expression of Noncanonical Wnt Receptor ROR2 To Alter Trophoblast Migration.
van Zuylen WJ; Ford CE; Wong DD; Rawlinson WD
J Virol; 2016 Jan; 90(2):1108-15. PubMed ID: 26559837
[TBL] [Abstract][Full Text] [Related]
16. ROR1 and ROR2 play distinct and opposing roles in endometrial cancer.
Henry CE; Llamosas E; Daniels B; Coopes A; Tang K; Ford CE
Gynecol Oncol; 2018 Mar; 148(3):576-584. PubMed ID: 29395309
[TBL] [Abstract][Full Text] [Related]
17. ROR2 inhibits the proliferation of gastric carcinoma cells via activation of non-canonical Wnt signaling.
Yan L; Du Q; Yao J; Liu R
Exp Ther Med; 2016 Dec; 12(6):4128-4134. PubMed ID: 28101190
[TBL] [Abstract][Full Text] [Related]
18. Cancer-associated fibroblasts influence Wnt/PCP signaling in gastric cancer cells by cytoneme-based dissemination of ROR2.
Rogers S; Zhang C; Anagnostidis V; Liddle C; Fishel ML; Gielen F; Scholpp S
Proc Natl Acad Sci U S A; 2023 Sep; 120(39):e2217612120. PubMed ID: 37722040
[TBL] [Abstract][Full Text] [Related]
19. Wnt5a induces homodimerization and activation of Ror2 receptor tyrosine kinase.
Liu Y; Rubin B; Bodine PV; Billiard J
J Cell Biochem; 2008 Oct; 105(2):497-502. PubMed ID: 18615587
[TBL] [Abstract][Full Text] [Related]
20. Insight into the role of Wnt5a-induced signaling in normal and cancer cells.
Endo M; Nishita M; Fujii M; Minami Y
Int Rev Cell Mol Biol; 2015; 314():117-48. PubMed ID: 25619716
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
